Synergy of trimethoprim-sulfamethoxazole.
作者信息
Bushby S R
出版信息
Can Med Assoc J. 1975 Jun 14;112(13 Spec No):63-6.
Abstract
摘要
相似文献
1
Synergy of trimethoprim-sulfamethoxazole.甲氧苄啶-磺胺甲恶唑的协同作用。
Can Med Assoc J. 1975 Jun 14;112(13 Spec No):63-6.
2
Mechanism of action of trimethoprim-sulfamethoxazole. I.
J Infect Dis. 1973 Nov;128:Suppl:433-6 p. doi: 10.1093/infdis/128.supplement_3.s433.
3
Co-trimaxazole therapy: place and prospects.复方新诺明疗法：地位与前景。
Med J Aust. 1973 Jun 30;1(2):Suppl:19-25.
4
Sensitivity testing with trimethorpim-sulphamethoxazole.用甲氧苄啶-磺胺甲恶唑进行敏感性测试。
Med J Aust. 1973 Jun 30;1(2):Suppl:10-8.
5
Biochemical background of trimethoprim-sulphamethoxazole.甲氧苄啶-磺胺甲恶唑的生化背景。
Med J Aust. 1973 Jun 30;1(2):Suppl:5-9. doi: 10.5694/j.1326-5377.1973.tb111178.x.
6
[In vitro sensitivity of human pathogens to the drug combination sulfamethoxazole-trimethoprim].[人类病原体对磺胺甲恶唑-甲氧苄啶药物组合的体外敏感性]
Schweiz Med Wochenschr. 1971 Sep 25;101(38):1385-90.
7
8
[Sensitivity of bacterial strains to Biseptol. I. Effect of Biseptol, sulfamethoxazole and trimethoprim against Gram-negative bacteria].
Med Dosw Mikrobiol. 1974;26(4):281-9.
9
[In-vitro activity of Eusaprim].[优沙普明的体外活性]
Minerva Med. 1973 May 16;64(34):1835-8.
10
引用本文的文献
1
Clinical Pharmacist Involved in the Treatment of Pneumonia: A Case Report.临床药师参与肺炎治疗：一例报告
Infect Drug Resist. 2024 Nov 11;17:5001-5010. doi: 10.2147/IDR.S477404. eCollection 2024.
2
Nocardia keratitis presenting as an anterior chamber ball of exudates and its management.表现为前房积脓性角膜溃疡的诺卡菌性角膜炎及其处理
BMJ Case Rep. 2023 Feb 21;16(2):e251647. doi: 10.1136/bcr-2022-251647.
3
Characterization of Stenotrophomonas maltophilia phage AXL1 as a member of the genus Pamexvirus encoding resistance to trimethoprim-sulfamethoxazole.鉴定嗜麦芽寡养单胞菌噬菌体 AXL1 为属于 Pamexvirus 属的病毒，编码对甲氧苄啶-磺胺甲噁唑的耐药性。
Sci Rep. 2022 Jun 18;12(1):10299. doi: 10.1038/s41598-022-14025-z.
4
Optimization of 2-Acylaminocycloalkylthiophene Derivatives for Activity against RnpA.2-酰基氨基环烷基噻吩衍生物抗RnpA活性的优化
Antibiotics (Basel). 2021 Mar 31;10(4):369. doi: 10.3390/antibiotics10040369.
5
Artificial Activation of and Toxin-Antitoxin Systems by Antisense Peptide Nucleic Acids as an Antibacterial Strategy.通过反义肽核酸人工激活毒素 - 抗毒素系统作为一种抗菌策略
Front Microbiol. 2018 Nov 26;9:2870. doi: 10.3389/fmicb.2018.02870. eCollection 2018.
6
Mutual potentiation drives synergy between trimethoprim and sulfamethoxazole.甲氧苄啶与磺胺甲噁唑的协同作用是相互促进的。
Nat Commun. 2018 Mar 8;9(1):1003. doi: 10.1038/s41467-018-03447-x.
7
LpxK Is Essential for Growth of ATCC 19606: Relationship to Toxic Accumulation of Lipid A Pathway Intermediates.LpxK对ATCC 19606的生长至关重要：与脂多糖A途径中间体的毒性积累的关系。
mSphere. 2017 Jul 26;2(4). doi: 10.1128/mSphere.00199-17. eCollection 2017 Jul-Aug.
8
Results of a randomized, prospective, double-dummy, double-blind trial to compare efficacy and safety of a herbal combination containing herba and radix with co-trimoxazole in patients with acute and uncomplicated cystitis.一项随机、前瞻性、双模拟、双盲试验的结果，该试验旨在比较一种含有[草药名]和[根类药名]的草药组合与复方新诺明在急性单纯性膀胱炎患者中的疗效和安全性。
Res Rep Urol. 2017 Mar 14;9:43-50. doi: 10.2147/RRU.S121203. eCollection 2017.
9
Anti-folates potentiate bactericidal effects of other antimicrobial agents.抗叶酸剂可增强其他抗菌剂的杀菌效果。
J Antibiot (Tokyo). 2017 Mar;70(3):285-291. doi: 10.1038/ja.2016.159. Epub 2017 Jan 11.
10
Design and Synthesis of a Focused Library of Diamino Triazines as Potential Mycobacterium tuberculosis DHFR Inhibitors.作为潜在结核分枝杆菌二氢叶酸还原酶抑制剂的二氨基三嗪聚焦文库的设计与合成
ACS Med Chem Lett. 2015 Oct 17;6(11):1140-4. doi: 10.1021/acsmedchemlett.5b00367. eCollection 2015 Nov 12.
本文引用的文献
1
IMPROVED METHOD FOR THE ISOLATION OF THYMINE-REQUIRING MUTANTS OF ESCHERICHIA COLI.改进的大肠杆菌胸腺嘧啶需求突变体分离方法。
J Bacteriol. 1965 Aug;90(2):554-5. doi: 10.1128/jb.90.2.554-555.1965.
2
5-BENZYL-2,4-DIAMINOPYRIMIDINES AS ANTIBACTERIAL AGENTS. I. SYNTHESIS AND ANTIBACTERIAL ACTIVITY IN VITRO.5-苄基-2,4-二氨基嘧啶类抗菌剂。I. 体外合成与抗菌活性
J Med Pharm Chem. 1962 Nov;5:1103-23. doi: 10.1021/jm01241a004.
3
The biosynthesis of folic acid. II. Inhibition by sulfonamides.叶酸的生物合成。II. 磺胺类药物的抑制作用。
J Biol Chem. 1962 Feb;237:536-40.
4
Trimethoprim: laboratory and clinical studies.甲氧苄啶：实验室研究与临床研究
J Clin Pathol. 1968 Mar;21(2):202-9. doi: 10.1136/jcp.21.2.202.
5
Trimethoprim, a sulphonamide potentiator.甲氧苄啶，一种磺胺增效剂。
Br J Pharmacol Chemother. 1968 May;33(1):72-90. doi: 10.1111/j.1476-5381.1968.tb00475.x.
6
Resistance of Staphylococcus aureus to sulphamethoxazole and trimethoprim.金黄色葡萄球菌对磺胺甲恶唑和甲氧苄啶的耐药性。
J Clin Pathol. 1972 Aug;25(8):708-12. doi: 10.1136/jcp.25.8.708.
7
[Extra-chromosomal, transmissible antibiotic resistance in human pathogens].
Hippokrates. 1972 Mar;43(1):45-60.
8
Antimicrobial sensitivity patterns as a guide to the domiciliary treatment of urinary tract infections.
Med J Aust. 1972 Feb 26;1(9):442.
9
Folate antagonists as antibacterial and antiprotozoal agents.作为抗菌和抗原生动物药物的叶酸拮抗剂。
Ann N Y Acad Sci. 1971 Nov 30;186:444-51. doi: 10.1111/j.1749-6632.1971.tb31171.x.
10
Reversal of the antimicrobial activity of trimethoprim by thymidine in commercially prepared media.在商业制备的培养基中，胸腺嘧啶核苷可逆转甲氧苄啶的抗菌活性。
Appl Microbiol. 1971 Nov;22(5):812-7. doi: 10.1128/am.22.5.812-817.1971.
Zotero 插件